Henrietta Lacks' Family Reaches Settlement with Novartis Over HeLa Cells

The family of Henrietta Lacks has reached a confidential settlement with Novartis, resolving a lawsuit that accused the pharmaceutical company of unjustly profiting from the use of her cells, known as HeLa cells. These cells were taken from Lacks without her knowledge in 1951 during treatment for cervical cancer at Johns Hopkins Hospital. The lawsuit, filed in federal court in Maryland, claimed that Novartis utilized the HeLa cell line in research and development without compensating Lacks' estate, which has faced financial struggles over the years. The terms of the settlement remain undisclosed, but both parties expressed satisfaction in resolving the matter outside of court.

Henrietta Lacks Family Secures Settlement With Novartis Over HeLa CellsNovartis Settles With Henrietta Lacks’ Estate

HeLa cells, derived from Lacks' tumor, became the first immortal human cell line, allowing for continuous growth and reproduction in laboratory settings. They have been instrumental in numerous medical advancements, including the development of the polio vaccine, cancer treatments, HIV and AIDS research, gene mapping, cloning, and in vitro fertilization. Despite the significant contributions of HeLa cells to science and medicine, Lacks' family has not received compensation, highlighting issues of exploitation within a racially biased medical system.

Henrietta Lacks Family Secures Settlement With Novartis Over HeLa Cells

This settlement with Novartis marks the second resolution in a series of lawsuits filed by Lacks' estate against various biomedical companies. In 2023, the estate reached a separate undisclosed settlement with Thermo Fisher Scientific, which also faced allegations of profiting from the HeLa cells. Other lawsuits against companies such as Ultragenyx Pharmaceutical and Viatris are still pending, indicating that the fight for accountability and compensation for the Lacks family continues.

Novartis Settles With Henrietta Lacks’ EstateHenrietta Lacks Family Secures Settlement With Novartis Over HeLa Cells

Critics have pointed to the broader implications of Lacks' story, emphasizing the exploitation of Black patients in medical research. The Lacks family's legal actions are seen as a response to a history of unethical practices in the medical field, where individuals like Lacks were treated as mere subjects rather than as people deserving of respect and compensation. Civil rights attorney Benjamin Crump, representing the Lacks estate, stated that the agreement with Novartis represents a significant step toward justice for the family.

Henrietta Lacks Family Secures Settlement With Novartis Over HeLa Cells

• “For the family and her grandchildren, this is certainly justice because people said they would never realize any benefit or compensation from her immortal HeLa cells, even though these pharmaceutical companies were profiting billions and billions of dollars,” — Benjamin Crump, Civil Rights Attorney

Henrietta Lacks Family Secures Settlement With Novartis Over HeLa Cells

The settlement between Henrietta Lacks' family and Novartis underscores the ongoing struggle for recognition and compensation in the realm of medical ethics. As the legacy of HeLa cells continues to impact scientific research, the Lacks family's pursuit of justice highlights the need for accountability in the medical community, particularly regarding the treatment of marginalized individuals.

Henrietta Lacks Family Secures Settlement With Novartis Over HeLa Cells